Navigation Links
U Alberta researcher in same group as Darwin and Hawking
Date:7/6/2009

EdmontonJohn Vederas, a University of Alberta professor in the department of chemistry, has been named to the Royal Society, the national academy of science of the United Kingdom and the Commonwealth. The ceremony takes place the week of July 6 in London.

Included in the Royal Society's membership are Isaac Newton, Charles Darwin and Stephen Hawking. There are more than 60 Nobel laureates among the society's 1,400 members.

Vederas is being recognized for a body of research that centers on the identification of antibiotic peptides in bacteria. Antibiotic peptides play an important role in food preservation and may have potential for human use, such as combating hospital-acquired infections. Peptides are 1,000 to 1 million times more active than conventional antibiotics and are effective against infectious bacteria resistant to commonly used antibiotics. Currently, more than 50 per cent of hospital-acquired infections are resistant to common antibiotics. Veredas' work also centres around biosynthesis by fungi of important metabolites including cholesterol-lowering drugs such as statins.

"The appointment is a great honour and I was very surprised and pleased," said Vederas. "The Royal Society has many programs to advise and assist scientists and government policy makers, as well as promote understanding science by the general public. I certainly plan to participate in some of these activities as a new fellow of the Royal Society."

Vederas joined the University of Alberta in 1977. He obtained a bachelor of science degree from Stanford University and a PhD from the Massachusetts Institute of Technology. Vederas has received several awards for research and teaching at the U of A. He has written more than 235 research publications and has created 13 patents.


'/>"/>

Contact: Brian Murphy
brian.murphy@ualberta.ca
780-492-6041
University of Alberta
Source:Eurekalert

Page: 1

Related biology news :

1. University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
2. Ancient reptile rises from Alberta oil sands
3. A new dinosaur species, Pachyrhinosaur lakustai, unveiled from Pipestone Creek, Alberta, Canada
4. New dinosaur species possible in Northwestern Alberta
5. Researchers identify proteins involved in new neurodegenerative syndrome
6. Texas researchers and educators head for Antarctica
7. MGH researchers describe new way to identify, evolve novel enzymes
8. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
9. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
10. U of MN researchers discover noninvasive diagnostic tool for brain diseases
11. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2015)... , May 14, 2015  Verificient Technologies, ... verification and online remote proctoring, announced a ... (SaaS) company and creator of the Canvas ... the two companies will benefit from the ... As a fully integrated multifactor ...
(Date:5/8/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leading ... the executive management team will present at the following investor ... Telecom Conference Date: May 18, 2015 Time: 10:40am ... Cowen and Company Technology, Media & ... The New York Palace Hotel, New York, NY ...
(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... break down cellulose (chunks of wood pulp), a process ... chemicals like chlorine. Nature performs the same task using ... far less energy. The catch is that the enzymes ... hold up to the high temperatures of the manufacturing ...
... Technology (NIST) and in Lithuania have used a NIST-developed ... detect and measure a protein associated with a serious ... The work illustrates how the artificial membrane could be ... bacteria Gardnerella vaginalis , BV is a very ...
... This news release is available in German . ... the death of thousands of neurons in the brain. Nerve growth ... of the neurons; however, clinical tests with GDNF have not yielded ... Neurobiology in Martinsried and their colleagues have now succeeded in demonstrating ...
Cached Biology News:Expanding the range of nature's catalysts for industrial applications 2Expanding the range of nature's catalysts for industrial applications 3NIST cell membrane model studied as future diagnostic tool 2Parkinson gene: Nerve growth factor halts mitochondrial degeneration 2Parkinson gene: Nerve growth factor halts mitochondrial degeneration 3
(Date:6/1/2015)... , May 29, 2015 ... the addition of the "2015 Assessments ... Major Suppliers and Recent Market Entrants" ... new 90-page report from VPGMarketResearch.com provides insightful ... recent market entrants. The report ...
(Date:6/1/2015)... -- Hutchison China MediTech Limited ("Chi-Med") ... ("AstraZeneca"), Hutchison MediPharma Limited,s ("HMP") collaboration partner, presented ... trial of HMP,s c-Met inhibitor savolitinib (AZD6094) combined ... lung cancer ("NSCLC"). AZD9291 is AstraZeneca,s ... (EGFR). Preliminary data on the activity of AZD9291 ...
(Date:5/31/2015)... , June 1, 2015 ... rare diseases, has selected Veeva Commercial Cloud to ... and medical. A complete solution, Veeva Commercial ... and compliant content to provide a comprehensive view ... execution.      (Logo: http://photos.prnewswire.com/prnh/20120425/527164) , ...
(Date:5/31/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... and drug-delivery therapies, today announced interim findings from ... investigational new drug PEGPH20 for the potential treatment ... The encouraging interim data was presented today at ... in an oral presentation by Principal Investigator ...
Breaking Biology Technology:Assessments of Leading Microbiology Market Players 2015 - Profiles of Major Suppliers and Recent Market Entrants 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud 2Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud 3Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 2Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 3Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 4Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients 5
... , MADEIRA BEACH, Fla. , ... – Mr. Diabetes®, Executive Director of Defeat Diabetes Foundation and ... the ProtoKinetix (PKTX) Advisory Board.  ProtoKinetix, Inc. is a biotechnology ... anti-aging glycoproteins (AAGP™) for medicine and the biotechnology and cosmetic ...
... , Editors say the new mission statement ... of biological research , BETHESDA, Md. , Jan. 14 ... week a number of changes to the journal,s publishing policies. They ... of biological research and will help the journal better meet the ...
... , , , , ... Sweden , January 14 Karolinska,Development AB and ... enrich the flow of investment opportunities available to,Karolinska Development and ... agreement involves evaluation of,potential investments; advise to existing portfolio companies ...
Cached Biology Technology:Andrew P. Mandell - Mr. Diabetes(R) to Sit On ProtoKinetix Advisory Board 2Journal of Biological Chemistry Changes Approach to Manuscript Reviews and Eliminates Submission Fees 2Journal of Biological Chemistry Changes Approach to Manuscript Reviews and Eliminates Submission Fees 3Karolinska Development and Uminova Invest Sign Co-operation Agreement 2
... P450 (CYP450) metabolite postulated to play an ... vasculature. In rat cerebral microvessels, 20-HETE is ... 20-HETE is excreted mainly as the glucuronide ... pg/ml in human urine) is about 10-fold ...
... Most sensitive silver stain. ... stop baths or reversers needed. ... and polysaccharides. Linear protein-to-stain ... stain multiple gels per tray. ...
... are designed to rapidly and reliably amplify ... APA Technology. APAgene provides hassle-free, ready-to use ... necessary ingredients are provided in each kit. ... for gap filling, localized cloning of genomic ...
Rabbit polyclonal to Quinaldic Acid ( Abpromise for all tested applications). Antigen: Synthetic peptide Quinaldic Acid conjugated to a protein carrier....
Biology Products: